Last reviewed · How we verify

NCT06192446

Factors Influencing Adherence to Adjuvant Endocrine Therapy

Status unknown Last updated 11 January 2024
What this trial tests

trial testing Survey using a questionnaire. in Adherence, Treatment in 1,000 participants. Status unknown.

Timeline
20 September 2021
Primary endpoint
20 September 2024
20 September 2024

Quick facts

Lead sponsorUniversity of Zagreb
StatusStatus unknown
Study typeOBSERVATIONAL
Enrollment1,000
Start date20 September 2021
Primary completion20 September 2024
Estimated completion20 September 2024
Sites1 location across Croatia

Drugs / interventions tested

Conditions studied

Sponsor

University of Zagreb

Who can join

18 and older, female only, with Adherence, Treatment. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

Breast cancer is the most common type of cancer and the leading cause of cancer death in women. Adjuvant endocrine therapy (AET) reduces the risk of disease recurrence and mortality in women with hormone-dependent breast cancer. This cross-sectional study aims to investigate adherence to AET and identify factors associated with adherence in the Republic of Croatia. The level of adherence, beliefs about medicines, and quality of life with AET will be investigated with validated instruments in the form of an anonymous survey. Given the available data on suboptimal adherence to AET in Europe and globally, it is clear that there is a need for investigating adherence in Croatia which hasn't been done so far. Each country, population, and health system has its own characteristics, and understanding the experience of using AET and identifying associated psychosocial factors could help in developing specific interventions supporting women and improving AET adherence.

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other trials of Survey using a questionnaire.

Trials testing the same drug.

Other recruiting trials for Adherence, Treatment

Currently open trials in the same condition.

Other University of Zagreb trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT06192446.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing